Close Menu

The Scan

A blogger returns from the ashes of a broken memory card to fix his programming problem.

The blog Effect Measure weighs in on the news that David Schwartz has temporarily stepped aside as NIEHS director.

Don't Read. Just Vote

It's your chance to help defend the Human Genome Project!

Following on the heels of the tightlipped 23andMe, a company launches to bring genotyping to the mass market.

Jonathan Eisen points out a press release that oversells genomics on what was otherwise a perfectly respectable study of gene expression in sharks.

The debate continues on whether biologists need computer programming skills.

Let's Go to the Video

A blogger describes SciVee, one of the latest science-focused video sites to launch.

Science reports on translational medicine, ultra-conserved genomic sequences, HIV, and more.

Freeman Dyson writes about heresy and science.

Amgen announces massive layoffs in response to declining drug sales.

The FDA steps up for personalized medicine.

A blogger expounds on why controls are necessary in biological research.

Chinese pigs are coming down with blue-ear disease.

Nature reports on evolving enzymes, computational biology, Nina Fedoroff, and more.

Tech Review publishes its annual list of young innovators.

Stephen Colbert's comedy show has a tour de force DNA special edition.

Sandra Porter blogs on accuracy issues with DNA sequence.

It was just a matter of time till Google took over health records. A sneak peek and review.

MIT researchers have developed a microscope that generates real-time images of cells.

In today's NYT, John Tierney writes that we're almost certainly living in somebody else's virtual world.

Impact factors lead to unscrupulous researchers, says an editorial in Current Biology.

The first human trials for a DNA-based vaccine for multiple sclerosis have been declared a success.

A blogger argues that patents stifle research.

Intellectual property rights distract universities from their original purpose, says a blogger.

In the blogosphere: what does creative commons mean for you?

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.